Delivery Order SPE2D021DA002-SPE2D322F110F
Award Date 5/10/22
Potential Completion Date 5/11/22
Potential Value $1.1K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide ENGERIX-B 20 MCG/ML SYRN. The order has a potential value of $1,119.33 and a completion date of August 11, 2022. This delivery order is part of a larger indefinite delivery contract with DMS Pharmaceutical Group to supply a variety of pharmaceutical and medical products to military treatment facilities worldwide, with a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $7,878.00, is for the supply of ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product, to support the medical supply needs of military health facilities. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at $499,999,999 and valid through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The $4,477.32 order is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product. This delivery order is likely part of a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to provide a variety of pharmaceutical and medical supplies to support military treatment facilities worldwide....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The $3,731.10 order is for the pharmaceutical product ENGERIX-B 20 MCG/ML SYRN. The delivery order was awarded on January 31, 2022, with a completion date of February 1, 2022. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple contracts and indefinite delivery vehicles (IDVs) with the...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide ENGERIX-B 20 MCG/ML SYRN for a potential value of $3,731.10. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to supply a variety of pharmaceutical and medical products to support military treatment facilities worldwide. The contract does not...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product, with a potential value of $4,680.96. The delivery order has a completion date of May 17, 2023. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product, with a ceiling value of $1,968.40 and a performance period through March 14, 2024. The contract is a firm fixed-price delivery order, which means DLA can issue orders against this contract for a variety of pharmaceutical items to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product, for a potential value of $1,828.85. This delivery order was issued against an indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA Troop Support Medical to supply pharmaceutical and medical products to support military treatment facilities...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,731.10 firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide ENGERIX-B 20 MCG/ML SYRN, a vaccine product. This delivery order was placed against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply a wide range of pharmaceutical and medical supplies to military treatment facilities worldwide. The overall contract vehicle has a potential value...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product. The delivery order is valued at $7,462.20 and has a completion date of September 14, 2022. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a variety of brand and generic prescription and over-the-counter drug supplies to the federal...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D322F110FDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of the pharmaceutical product ENGERIX-B 20 MCG/ML SYRN. The potential value of this order is $1,119.33. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with the DLA to provide a variety of pharmaceutical and medical supplies to military treatment facilities worldwide, with a potential value up to $5 million through December 2025. The contract does not have a set-aside designation.
Generated 4/24/24, 12:02 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/10/22 |